Bio-Rad Laboratories, Inc. (BIO) stock analysis

In our weekly check, Bio-Rad Laboratories, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 10 pass, warnings: 7, red flags: 7.

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as BIO.

What our checks show for BIO

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-11

Similar companies

GMED · BRKR · PODD · ALGN · PEN · SNN

Questions

What grade does Bio-Rad Laboratories, Inc. (BIO) have?

In our weekly check, Bio-Rad Laboratories, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 10 pass, warnings: 7, red flags: 7. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of BIO stock?

This week's biggest flags for Bio-Rad Laboratories, Inc.: Margins falling, Gross margin falling, Profits not backed by cash. In total 14 of 24 checks show a warning or a red flag.

What does Bio-Rad Laboratories, Inc. do?

Bio-Rad Laboratories, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as BIO.

When does Bio-Rad Laboratories, Inc. report earnings next?

The next earnings report is expected on 2027-02-11. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis